Lindbrook Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $609K | Sell |
8,774
-1,279
| -13% | -$88.8K | 0.06% | 195 |
|
2024
Q4 | $865K | Sell |
10,053
-682
| -6% | -$58.7K | 0.08% | 151 |
|
2024
Q3 | $1.28M | Buy |
10,735
+346
| +3% | +$41.2K | 0.11% | 115 |
|
2024
Q2 | $1.48M | Buy |
10,389
+271
| +3% | +$38.7K | 0.14% | 96 |
|
2024
Q1 | $1.3M | Buy |
10,118
+231
| +2% | +$29.7K | 0.12% | 106 |
|
2023
Q4 | $1.02M | Sell |
9,887
-180
| -2% | -$18.6K | 0.1% | 118 |
|
2023
Q3 | $915K | Buy |
10,067
+255
| +3% | +$23.2K | 0.1% | 113 |
|
2023
Q2 | $794K | Buy |
9,812
+16
| +0.2% | +$1.3K | 0.08% | 137 |
|
2023
Q1 | $779K | Buy |
9,796
+74
| +0.8% | +$5.89K | 0.09% | 131 |
|
2022
Q4 | $658K | Buy |
9,722
+378
| +4% | +$25.6K | 0.08% | 152 |
|
2022
Q3 | $465K | Buy |
9,344
+56
| +0.6% | +$2.79K | 0.08% | 152 |
|
2022
Q2 | $517K | Buy |
9,288
+1,714
| +23% | +$95.4K | 0.09% | 148 |
|
2022
Q1 | $421K | Sell |
7,574
-98
| -1% | -$5.45K | 0.07% | 180 |
|
2021
Q4 | $430K | Buy |
7,672
+356
| +5% | +$20K | 0.07% | 180 |
|
2021
Q3 | $351K | Buy |
7,316
+134
| +2% | +$6.43K | 0.09% | 92 |
|
2021
Q2 | $301K | Sell |
7,182
-176
| -2% | -$7.38K | 0.07% | 122 |
|
2021
Q1 | $248K | Buy |
7,358
+764
| +12% | +$25.8K | 0.06% | 132 |
|
2020
Q4 | $230K | Buy |
6,594
+98
| +2% | +$3.42K | 0.06% | 128 |
|
2020
Q3 | $226K | Sell |
6,496
-22
| -0.3% | -$765 | 0.06% | 117 |
|
2020
Q2 | $213K | Buy |
6,518
+300
| +5% | +$9.8K | 0.06% | 115 |
|
2020
Q1 | $187K | Sell |
6,218
-1,850
| -23% | -$55.6K | 0.07% | 106 |
|
2019
Q4 | $233K | Sell |
8,068
-112
| -1% | -$3.24K | 0.08% | 122 |
|
2019
Q3 | $211K | Sell |
8,180
-158
| -2% | -$4.08K | 0.08% | 123 |
|
2019
Q2 | $212K | Buy |
8,338
+402
| +5% | +$10.2K | 0.08% | 125 |
|
2019
Q1 | $207K | Buy |
7,936
+364
| +5% | +$9.49K | 0.08% | 123 |
|
2018
Q4 | $174K | Buy |
+7,572
| New | +$174K | 0.09% | 124 |
|